FoliuMed
Oliver Zugel is the Founder and CEO of FoliuMed, a producer of pharmaceutical dosage forms made in Germany from a low-cost cultivation facility in Colombia. Prior to FoliuMed, Oliver was the Co-founder and Chairman of Taproot Holdings, a producer of high THC products for the Nevada adult use market. Oliver also served as the Chief Restructuring Officer at Codere, a multinational gaming company, and as the Founder and CEO of Spring Capital, a firm specializing in principal investment, M&A, and strategy advisory services. Oliver has also held executive positions at Peralada Group/Casino Barcelona and Monitor Group. Oliver holds a First Class Honours Bsc in International Economics & Development from The London School of Economics and Political Science.
This person is not in any teams
This person is not in any offices
FoliuMed
FoliuMed is a producer of pharma-grade cannabis extracts for the medical cannabis and wellness markets. We grow proprietary CBD and THC strains at our Colombian farm and convert them into active pharmaceutical ingredients and medical cannabis products at the EU-GMP certified facility of our JV partners Fidelio in Germany. Our business is built around 3 major principles: 1. Affordability. Cannabis is too expensive and our low cost cultivation in Colombia allows us to offer products at a fraction of today's price. 2. Oral administration forms. European doctors will not prescribe cannabis flowers once they can access safer alternatives like extracts, capsules or sprays which we co-develop with our German partners. 3. Pharma-grade quality. We grow and extract our own cannabis in Colombia under the EU-GMP quality guidelines of Fidelio.